Position
BRAIDWELL LP in Neurocrine Biosciences Inc
Back to the book · All holders of NBIX
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$6.58M$141.83 → $131.74
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 751.5K | $106.6M | — | — | — | 3.4% |
| Q1 2026 | 652.1K | $85.9M | $131.74 | −$6.58M | −$14.1M | 2.9% |